💡#AI is only as good as the data it learns from. 💡 High-quality, deep-clinical data is the foundation of PhenOM AI models, shaping the ability to make accurate predictions and insightful analyses for reliable decisions. 💡 View the full DIA interview with Rich Gliklich, CEO, OM1 and Ebony Dashiell-Aje, PhD, Executive Director and Head, Patient Centered Outcomes Science at BioMarin Pharmaceutical Inc. 📍Full Interview: https://hubs.ly/Q02GKPcL0 📍PhenOM ebook: https://hubs.ly/Q02GKvL50 #MachineLearning #PersonalizedMedicine #HealthAI #RWE
About us
OM1 is an insights-driven technology and data company specializing in Personalized Medicine, Evidence Generation, and RWE Research powered by next-Gen A.I. platforms, regulatory-grade deep longitudinal data, and globally recognized thought leadership. Our unprecedented innovation takes RWE from Bench-to-Practice, delivering unparalleled personalized impact on the outcomes of patients and the advancement of research. We do things differently. We are pushing the boundaries of healthcare, reimagining how industry, providers, payers, and patients use real-world evidence. We are globally recognized for the integration of cutting-edge AI and data technologies. As pioneers in the field, our commitment to leveraging technology propels healthcare transformation, enhancing patient outcomes and setting new industry benchmarks.
- Website
-
http://www.om1.com
External link for OM1, Inc.
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Boston, Massachusetts
- Type
- Privately Held
- Founded
- 2015
- Specialties
- Health Data, Health Outcomes, Patient Reported Outcomes, Predictive Analytics, Outcomes Measurement, Outcomes Management, Value-Based Care, Real-World Evidence, Big Data, and Registries
Products
Locations
-
Primary
31 Saint James Ave
Suite 1125
Boston, Massachusetts 02116, US
Employees at OM1, Inc.
Updates
-
Demonstrating value and outcomes has never been easier than with Orion, the cosmic alignment of predictive #AI analytics and real-world data, your guide to the most comprehensive patient journeys. 📍Book a meeting today and name your very own star! https://hubs.ly/Q02GgpTv0 #MachineLearning #PersonalizedMedicine #MedicalAffairs #Commercial #HEOR
-
🧠 Estimates of #TRD prevalence among adults with #MDD vary, but typically range between 30% and as high as 55%. 🧠 A leading pharmaceutical company conducted a study using the OM1 Mental Health & Neuroscience data network and found reductions in depressive symptoms associated with Esketamine Nasal Spray Therapy in patients with TRD. The average decrease in #PHQ9 scores among adherent patients was 6.6 compared to an average decrease of 3.6 among nonadherent patients. 🧠 Interested in learning more about what you can do with our data networks and insights? 📍Take a look at our #mentalhealth publications page for more: https://hubs.ly/Q02GnSDL0
-
Are you at a standstill in your patient journeys? Let Orion guide you with a comprehensive understanding of the patient journey like never before. 📍Read the PhenOM ebook for more: https://hubs.ly/Q02FTC7G0 #AI #MachineLearning #PersonalizedMedicine #MedicalAffairs #Commercial #HEOR
-
🌟 Stop just accessing data and unlock the transformative insights that drive meaningful impact across the entire healthcare ecosystem with Orion, the cosmic alignment of predictive #AI analytics and #realworlddata. 📍Book a meeting with us to learn more about PhenOM and name a star: https://hubs.ly/Q02FJclR0 #AI #MachineLearning #PersonalizedMedicine #MedicalAffairs #Commercial #HEOR
-
Employing #AI to fill in critical knowledge gaps within the patient journey and improve standard of care should never be opaque or cryptic. See the unseen using advanced and patented AI to build a complete journey. View the PhenOM playlist on YouTube to learn more about: ✅ Hidden patient phenotypic signatures ✅ Patient identification ✅ Diagnostic and treatment insights While you’re there, check out our other videos to see what else you can do with real-world data and AI. 📍https://hubs.ly/Q02DKSBm0
-
Real-world data provide insight into patient journeys, including around diagnosis, progression, and treatment. These insights are limited by what's available in the data, and traditional techniques can leave key questions unanswered. Listen as Joseph Zabinski, Ph.D. explains how PhenOM leverages #digitalphenotyping with #RWD, adding insights into the #patientjourney. 📍Watch the full webinar: https://hubs.ly/Q02Dzcd50 #AI #PersonalizedMedicine #RWE #Pharma #Biopharma #LifeSciences
-
🔍 Insights from the Largest Mental Health RWD Network Mental health is complex, but gaining valuable insights from real-world data shouldn’t be. Dive into our ebook to explore practical applications of real-world data and #AI in #mentalhealth and gain exclusive insights from OM1 research. 🔗 View the eBook: https://hubs.ly/Q02DjKgS0 #RWD #AI #RWE
-
"The automation of data collection, from electronic medical records and other systems, is emerging as a key means to simplify and improve #clinicalstudies. Some of the advantages of automation include accelerating study timelines, reducing costs, generating external control arms, reducing site burden, and increasing the diversity of participants who are enrolled." Rich Gliklich 📍Full article from Pharma's Almanac: https://hubs.ly/Q02D0X570 #AutomatedRegistries #DataAutomation #AI
-
🏳️⚧️ There are many barriers to reliable healthcare for transgender people that often contribute to delaying or avoiding needed medical care. 🏳️⚧️ According to The National Institutes of Health, transgender individuals who delayed healthcare because of fear of discrimination had worse general health in the past month than those who did not delay or delayed care for other reasons. 🏳️⚧️ #AI can help to identify patients in need for: ✅ Deeper insight into drivers of risk and treatment decision-making and outcomes ✅ Holistic view of real-world patient populations, including those ‘off the radar’ ✅ Seamless integration of transparent AI-derived insights with traditional data for robust and cohesive analyses 📍More from NIH: https://hubs.ly/Q02z_gwB0 📍Read our PhenOM ebook for more insights on patient identification: https://hubs.ly/Q02z_gtJ0 #PrideMonth
Transgender Noninclusive Healthcare and Delaying Care Because of Fear: Connections to General Health and Mental Health Among Transgender Adults
ncbi.nlm.nih.gov